Antigen processing influences HIV-specific cytotoxic T lymphocyte immunodominance
about
Identification of minimal human MHC-restricted CD8+ T-cell epitopes within the Plasmodium falciparum circumsporozoite protein (CSP)A peptide filtering relation quantifies MHC class I peptide optimizationChallenges and Opportunities for T-Cell-Mediated Strategies to Eliminate HIV ReservoirsMechanisms of HIV protein degradation into epitopes: implications for vaccine designAntigenic peptide trimming by ER aminopeptidases--insights from structural studiesHigh avidity CD8+ T cells efficiently eliminate motile HIV-infected targets and execute a locally focused program of anti-viral functionConstraints within major histocompatibility complex class I restricted peptides: Presentation and consequences for T-cell recognitionRationally designed inhibitor targeting antigen-trimming aminopeptidases enhances antigen presentation and cytotoxic T-cell responsesLarge scale analysis of phenotype-pathway relationships based on GWAS resultsA vaccine encoding conserved promiscuous HIV CD4 epitopes induces broad T cell responses in mice transgenic to multiple common HLA class II moleculesNewcastle disease virus-vectored vaccines expressing the hemagglutinin or neuraminidase protein of H5N1 highly pathogenic avian influenza virus protect against virus challenge in monkeys.CTL escape mediated by proteasomal destruction of an HIV-1 cryptic epitopeGeneration of robust CD8+ T-cell responses against subdominant epitopes in conserved regions of HIV-1 by repertoire mining with mimotopes.Design of immunogenic and effective multi-epitope DNA vaccines for melanoma.Protease cleavage sites in HIV-1 gp120 recognized by antigen processing enzymes are conserved and located at receptor binding sitesBalancing selection maintains a form of ERAP2 that undergoes nonsense-mediated decay and affects antigen presentation.Maintenance or emergence of chronic phase secondary cytotoxic T lymphocyte responses after loss of acute phase immunodominant responses does not protect SIV-infected rhesus macaques from disease progression.The antiviral efficacy of HIV-specific CD8⁺ T-cells to a conserved epitope is heavily dependent on the infecting HIV-1 isolate.Protective efficacy of serially up-ranked subdominant CD8+ T cell epitopes against virus challengesSubdominant/cryptic CD8 T cell epitopes contribute to resistance against experimental infection with a human protozoan parasite.Unique CRF01_AE Gag CTL epitopes associated with lower HIV-viral load and delayed disease progression in a cohort of HIV-infected Thais.POPISK: T-cell reactivity prediction using support vector machines and string kernels.The effect of HLA polymorphisms on the recognition of Gag epitopes in HIV-1 CRF01_AE infection.Development of a novel in silico docking simulation model for the fine HIV-1 cytotoxic T lymphocyte epitope mapping.Autologous HIV-1 clade-B Nef peptides elicit increased frequency, breadth and function of CD8+ T-cells compared to consensus peptides.Rapid antigen processing and presentation of a protective and immunodominant HLA-B*27-restricted hepatitis C virus-specific CD8+ T-cell epitope.A novel protective MHC-I haplotype not associated with dominant Gag-specific CD8+ T-cell responses in SIVmac239 infection of Burmese rhesus macaques.T Cell receptor clonotype influences epitope hierarchy in the CD8+ T cell response to respiratory syncytial virus infection.The immune response during acute HIV-1 infection: clues for vaccine development.The T-cell response to HIV.Location of the CD8 T cell epitope within the antigenic precursor determines immunogenicity and protection against the Toxoplasma gondii parasite.Properties of MHC class I presented peptides that enhance immunogenicityAlphavirus replicon DNA expressing HIV antigens is an excellent prime for boosting with recombinant modified vaccinia Ankara (MVA) or with HIV gp140 protein antigen.Comparison of immune responses generated by optimized DNA vaccination against SIV antigens in mice and macaquesBroad HIV epitope specificity and viral inhibition induced by multigenic HIV-1 adenovirus subtype 35 vector vaccine in healthy uninfected adultsHigh-functional-avidity cytotoxic T lymphocyte responses to HLA-B-restricted Gag-derived epitopes associated with relative HIV controlVaccine-induced HIV-specific CD8+ T cells utilize preferential HLA alleles and target-specific regions of HIV-1.Variable processing and cross-presentation of HIV by dendritic cells and macrophages shapes CTL immunodominance and immune escape.HIV-infected sex workers with beneficial HLA-variants are potential hubs for selection of HIV-1 recombinants that may affect disease progressionThe immune response to a vesicular stomatitis virus vaccine vector is independent of particulate antigen secretion and protein turnover rate.
P2860
Q21034050-8A97335A-C021-4805-98DA-1B530FDCCB4BQ21092515-F2B83ED0-0B60-49DD-80BE-7B21E2D68596Q26781511-E1C49C27-B356-44BD-B781-457A5D90D90BQ26866505-7F7DE6D0-571B-40BE-8B43-59851CED6461Q27009465-328EF0AF-C699-450A-AEDA-FEE3A189DB58Q27323727-DB8E5E25-2842-4BC5-B477-C2586C6A1903Q27660158-DA66C100-8D18-4A58-AEE1-2BFBBA609B99Q27680633-162B25AC-9EA4-42CE-9490-7A8C70990E72Q28540586-6F7D40B8-9192-46C9-916A-93F347B1AF05Q28751663-4B576D39-47F9-41DF-8563-2A8A1261FD39Q30382650-D1155714-AA7F-4526-A4C5-5ED75C7F1F3AQ31010282-DEE48ACB-8EC0-4387-BD4B-83EFE92A2974Q33568699-9A7D8A8D-5581-4335-B70E-8404DB640D9EQ33606546-9F42AFC3-EB6F-4ABF-B16F-EFEC7B713485Q33614461-A7024BBD-83CA-4502-A521-A419AEAFAD7DQ33728652-CDFB7008-1E3F-48A7-AA37-B80CE07CF7FCQ33879572-9101CC1F-1B1E-4A11-813B-C146AECBD8F4Q33904028-E236C4F8-84BD-447C-A4CD-6B4BD6396859Q33916635-57F59955-CE7B-4E19-B2C0-1FDC3FEDAB0BQ33968196-5D99F3A6-1C95-482A-8835-8D3FDA6B486BQ33985956-57C0E5BF-DF95-4E8A-BEC8-BB5AA6229099Q34074865-593C616B-0FC3-4FC6-9A2F-F657FADB76BDQ34358831-173B8A2C-87E4-4F14-AA38-C27541EA2FD7Q34358851-F0860762-B3E2-4214-A367-44529B00AEEDQ34490157-616B4ED9-7E3C-4DD2-8CBA-1DA919DCF0B8Q34499385-1109D54B-7636-4FC9-845F-43637880EA83Q34559322-9D298AB6-D1F6-4FE4-826B-3DC1964DABFDQ34575622-0A2626FD-68A7-4C69-A26D-971DB89B6A56Q34614862-C52DA7D4-5632-482F-871F-B6EC1C1F14FDQ34642996-ABEE17F8-AB64-415A-920B-9DB7528460ACQ34789311-A9FC3A47-0112-451B-9DD7-2B03D3917FCCQ35034097-F2BD5DAD-400F-4424-A5FE-10284E099248Q35038794-5E81D657-F189-4778-B0C7-4D2AE649FFEFQ35046349-FC4072F7-80DF-4873-A868-F81A7E02FD08Q35114907-77FF29B6-C38A-4958-8C76-BC315E4A8E4FQ35192655-96036CC5-8F07-41D9-873D-F4E01482B3C8Q35388181-1DE02DB0-B5D1-49A0-9DDC-6083BFC0704BQ35579689-9C64DC9F-B71B-4212-8BDD-E343BEB1AEC2Q35749934-DF6BDEAC-4B8A-4A15-BB5A-632EE0CD1564Q35867988-A5555F2C-530C-441D-B0C5-C10AFB76D9AC
P2860
Antigen processing influences HIV-specific cytotoxic T lymphocyte immunodominance
description
2009 nî lūn-bûn
@nan
2009 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Antigen processing influences HIV-specific cytotoxic T lymphocyte immunodominance
@ast
Antigen processing influences HIV-specific cytotoxic T lymphocyte immunodominance
@en
Antigen processing influences HIV-specific cytotoxic T lymphocyte immunodominance
@nl
type
label
Antigen processing influences HIV-specific cytotoxic T lymphocyte immunodominance
@ast
Antigen processing influences HIV-specific cytotoxic T lymphocyte immunodominance
@en
Antigen processing influences HIV-specific cytotoxic T lymphocyte immunodominance
@nl
prefLabel
Antigen processing influences HIV-specific cytotoxic T lymphocyte immunodominance
@ast
Antigen processing influences HIV-specific cytotoxic T lymphocyte immunodominance
@en
Antigen processing influences HIV-specific cytotoxic T lymphocyte immunodominance
@nl
P2093
P2860
P50
P3181
P356
P1433
P1476
Antigen processing influences HIV-specific cytotoxic T lymphocyte immunodominance
@en
P2093
Andrew J McMichael
Anne Burgevin
Astrid K N Iversen
Chih-hao Chang
E Yvonne Jones
Edmund Wee
Hansjörg Schild
Jan Gerstoft
Kasper Lamberth
Lars Fugger
P2860
P304
P3181
P356
10.1038/NI.1728
P407
P577
2009-06-01T00:00:00Z